The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling
暂无分享，去创建一个
J. Blachly | S. Sher | A. Mims | R. Lapalombella | N. Grieselhuber | J. Woyach | S. Orwick | Shaneice R Mitchell | V. Goettl | Karilyn T. Larkin | Britten Gordon | Yerdanos Asemelash | E. Whipp | Bonnie K. Harrington | Alexander Marr | Madeline Halpin | Dominique Corbin | Samon Benrashid | Vedat Yildiz | Andrew D. Mitchell | Olivia Cahn | Meixao Long